Close

Jack Williams

Research Fellow
in Health Economics

Room
Room 142

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

I joined the Health Services Research and Policy Department at LSHTM in 2017. My current research focuses on the cost-effectiveness of interventions to identify and diagnose individuals with Hepatitis B and C, and interventions to retain these individuals within care.


I also work with alongside the Clinical Trials Unit at LSHTM, helping to support health economic analyses, following the completion of trials, and helping to provide economic evidence for the value of performing research as part of a trial. This has included economic evaluations of tranexamic acid treatment for traumatic brain injury and gastrointestinal bleeding.


I completed by MSc in Public Health (Health Economics stream) at LSHTM. My MSc thesis was looking the cost-effectiveness of a spinal screening intervention for patients with metastatic prostate cancer. I have previously worked in Health Economic modelling for a private consultancy, working on cost-effectiveness and budget impact models, mostly for HTA submissions, in a variety of disease areas.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Global Health Economics Centre

Teaching

I am a seminar leader for Introduction to Health Economics and Economic Evaluations modules.

I also co-developed the R stream for both the Foundations and Advanced Decision Modelling for Health Economic Evaluation short course, delivered jointly by LSHTM and the University of York (https://modelling.he-evalcourses.com). I am also a tutor on the course.

Research

Research Area
Clinical guidelines
Decision analysis
Economic evaluation
Health inequalities
Viruses
Modelling
Discipline
Health economics
Region
European Union

Selected Publications

Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L
2021
Health technology assessment (Winchester, England)
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
Roberts K; Macleod J; Metcalfe C; Hollingworth W; Williams J; Muir P; Vickerman P; Clement C; Gordon F; Irving W
2020
BMJ (Clinical research ed.)
An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom.
Williams J; Vickerman P; Douthwaite S; Nebbia G; Hunter L; Wong T; Ruf M; Miners A
2020
VALUE IN HEALTH
Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation.
Martin NK; Vickerman P; Khakoo S; Ghosh A; Ramsay M; Hickman M; Williams J; Miners A
2019
BMJ open
Cost-Effectiveness of One-Time Birth Cohort Screening for Hepatitis C as Part of the National Health Service Health Check Program in England.
Williams J; Miners A; Harris R; Mandal S; Simmons R; Ireland G; Hickman M; Gore C; Vickerman P
2019
Value in Health
See more Publications